Please login to the form below

Not currently logged in

Welcome to PMEA

PMEA: Recognising excellence in improving patient outcomes

What is the PMEA programme?

PMEA rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

It reflects the dynamic healthcare environment and the industry’s development of new, intelligent ways to improve patient care and outcomes and provide greater value for healthcare providers and payers.

Each year the categories and programme are scrutinised to ensure that PMEA continues to be specifically designed to recognise and commend excellence, best practice and innovation in local, European and international markets. For 2018, there is one new category -

PMEA 2018 aims to…

1. Recognise work that delivers clearly identifiable benefits and improved outcomes for patients.

2. Recognise the value of responsible business practices that improve:

  • Standards of clinical practice
  • Provision of healthcare
  • Access to medical treatment or services
  • Uptake of treatment
  • Adherence and compliance with treatment
  • Coordination and delivery of services
  • Treatment benefits
  • Support for independence and management of risk

3. Identify and recognise the talented organisations behind the work.

4. Create an environment where success is valued and commended.

Why Enter PMEA?

Good work shouldn’t go unrecognised. Don’t miss your chance to be singled out for excellence in improving patient outcomes by a panel of experienced, independent industry judges. Being recognised through the PMEA programme is regarded as a significant achievement for the teams, companies, agencies and consultancies behind the initiatives.

Success at PMEA can be a key driver for business growth and for building morale with internal and external stakeholders alike.

Who can enter?

  • European, international or UK pharmaceutical, biotech, ethical, life science, OTC and medical device/diagnostic companies
  • Healthcare agencies and consultancies
  • Management consultants acting on behalf (and with the full authorisation) of the client pharmaceutical company
  • Patient associations and charities
  • Trade organisations and professional bodies.

“When AbbVie was formed five years ago, our vision was to have a remarkable impact for patients. This award is warmly welcomed as recognition that our relentless focus on our culture, our ways of working as well as our strategic execution, have created an organisation that we at AbbVie are proud to be part of.”
Gwenan White, UK Director of Communications and Patient Relations, AbbVie